World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
61241
World Ranking
6120
National Ranking
3274

Frederick L. Ferris publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Frederick L. Ferris sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 300 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Frederick L. Ferris D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Frederick L. Ferris sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Frederick L. Ferris is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the field of medicine, with significant contributions to ophthalmology, radiology, nuclear medicine and imaging, molecular biology, epidemiology, and endocrinology, diabetes, and metabolism.

The main subfields of study for Frederick L. Ferris include:

  • Ophthalmology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Epidemiology
  • Endocrinology, Diabetes and Metabolism

The topics they have extensively covered in their work relate mostly to retinal conditions and treatments. These include:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Retinal Development and Disorders
  • Ocular Diseases and Behçet's Syndrome
  • Ophthalmology and Visual Impairment Studies

Frederick L. Ferris has published numerous papers in several well-regarded ophthalmology and vision science journals. Frequent venues for their work include:

  • Translational Vision Science & Technology
  • Ophthalmology Retina
  • American Journal of Ophthalmology
  • Ophthalmology Science
  • Ophthalmology

Some recently published papers by Frederick L. Ferris are:

  • "Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration" (2020), published in Ophthalmology
  • "Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema" (2022), published in New England Journal of Medicine
  • "The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline" (2020), published in Translational Vision Science & Technology
  • "Diagnosing Persistent Hypertransmission Defects on En Face OCT Imaging of Age-Related Macular Degeneration" (2022), published in Ophthalmology Retina
  • "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" (2020), published in American Journal of Ophthalmology

Throughout their career, Frederick L. Ferris has collaborated regularly with several coauthors, including:

  • Maureen G. Maguire
  • Glenn J. Jaffe
  • Emily Y. Chew
  • David G. Birch
  • Jacque L. Duncan

Best Publications

  • Complement Factor H Polymorphism in Age-Related Macular Degeneration

    Robert J. Klein;Caroline J. Zeiss;Emily Y. Chew;Jen-yue Tsai

  • Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

    Charles P. Wilkinson;Frederick L. Ferris;Ronald Klein;Paul P. Lee

  • New visual acuity charts for clinical research

    Frederick L. Ferris;Aaron Kassoff;George H. Bresnick;Ian Bailey

  • Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

    Daniel F. Martin;Maureen G. Maguire;Stuart L. Fine;Gui Shuang Ying

  • Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

    Michael J. Elman;Lloyd Paul Aiello;Roy W. Beck;Neil M. Bressler

  • Clinical Classification of Age-related Macular Degeneration

    Frederick L. Ferris;C.P. Wilkinson;Alan Bird;Usha Chakravarthy

  • Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy

    Frederick L. Ferris;Stuart L. Fine;Leslie Hyman

  • Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

    John A Wells;Adam R Glassman;Allison R Ayala

  • Increased Prevalence of Myopia in the United States Between 1971-1972 and 1999-2004

    Susan Vitale;Robert D. Sperduto;Frederick L. Ferris

  • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

    Emily Y. Chew;Traci E. Clemons;John Paul SanGiovanni;Ronald Danis

  • Association of Elevated Serum Lipid Levels With Retinal Hard Exudate in Diabetic Retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22

    Emily Y. Chew;Michael L. Klein;Frederick L. Ferris;Nancy A. Remaley

  • Photocoagulation for diabetic macular edema.

    Lloyd M. Aiello;Frederick L. Ferris

  • Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

    John A. Wells;Adam R. Glassman;Allison R. Ayala;Lee M. Jampol

  • Senile macular degeneration: a case-control study.

    Leslie G. Hyman;Abraham M. Lilienfeld;Frederick L. Ferris;Stuart L. Fine

  • Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

    Arnall Patz;Stuart Fine;Daniel Finkelstein;Thaddeus Prout

  • Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

    Traci E Clemons;Roy C Milton;Ronald Klein;Johanna M Seddon

  • A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.

    Ferris Fl;Davis;Clemons Te;Lee Ly

  • Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials

    Maureen G. Maguire;Daniel F. Martin;Gui shuang Ying;Glenn J. Jaffe

  • Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

    Michael J. Elman;Neil M. Bressler;Haijing Qin;Roy W. Beck

  • Complement factor H polymorphism in age-related macular degeneration

    R.J. Klein;C. Zeiss;E.Y. Chew;J.Y. Tsai

Frequent Co-Authors

Emily Y. Chew
Emily Y. Chew National Institutes of Health
Neil M. Bressler
Neil M. Bressler Johns Hopkins University School of Medicine
Roy W. Beck
Roy W. Beck University of South Florida
Lloyd Paul Aiello
Lloyd Paul Aiello Harvard University
Susan B. Bressler
Susan B. Bressler Johns Hopkins University School of Medicine
Glenn J. Jaffe
Glenn J. Jaffe Duke University
Maureen G. Maguire
Maureen G. Maguire University of Pennsylvania
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
Cynthia A. Toth
Cynthia A. Toth Duke University
Chi-Chao Chan
Chi-Chao Chan National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA offers a wide range of online degrees and career pathways for aspiring and advancing healthcare professionals. For registered nurses seeking to expand their scope of practice, the 1 year dnp program online provides a fast-track route to a Doctor of Nursing Practice, allowing for leadership and advanced clinical roles.

Those looking for a quicker entry into healthcare can consider the fast track medical lpn option. This pathway enables students to become Licensed Practical Nurses in a relatively short period, opening up opportunities for immediate patient care roles.

Mental health is another in-demand field, and the fastest psychiatric nurse practitioner program can help registered nurses specialize quickly in psychiatric and mental health care, meeting growing needs in diverse communities.

Alternatively, if your interests lie in the administrative side of healthcare, numerous accredited online healthcare administration programs offer flexibility and affordability, preparing graduates for leadership positions in hospitals, clinics, and health organizations.

Best Scientists Citing Frederick L. Ferris

Trending Scientists

Recently Published Articles